CGRP-monoclonal antibodies and SARS-CoV-2 vaccination

J Neurol. 2022 Jun;269(6):2848-2849. doi: 10.1007/s00415-021-10946-3. Epub 2022 Jan 8.

Authors

Francesca Schiano di Cola¹, Salvatore Caratozzolo², Paolo Liberini², Alessandro Padovani², Renata Rao²

Affiliations

¹ Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, BS, Italy. francescaschiano@hotmail.it.
² Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, BS, Italy.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Neutralizing
Antibodies, Viral
Antineoplastic Agents, Immunological*
COVID-19 Vaccines
COVID-19* / prevention & control
Calcitonin Gene-Related Peptide
Humans
SARS-CoV-2
Vaccination

Substances

Antibodies, Monoclonal
Antibodies, Neutralizing
Antibodies, Viral
Antineoplastic Agents, Immunological
COVID-19 Vaccines
Calcitonin Gene-Related Peptide